董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Richard A. Berman | 男 | Director | 78 | 4.99万美元 | 未持股 | 2023-08-25 |
| Michael Sherman | 男 | Director,Chairman of the Board | 63 | 4.99万美元 | 未持股 | 2023-08-25 |
| James M. Messina | 男 | Director | 64 | 4.99万美元 | 未持股 | 2023-08-25 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Mary Louise Osborne | 女 | President and Chief Commercial Officer | 62 | 57.51万美元 | 未持股 | 2023-08-25 |
| James J. Park | 男 | Chief Financial Officer and Chief Accounting Officer | 46 | 未披露 | 未持股 | 2023-08-25 |
| Arik Hill | 男 | Chief Information Officer | 53 | 未披露 | 未持股 | 2023-08-25 |
| Judith Feld | 女 | Chief Medical Officer | 69 | 未披露 | 未持股 | 2023-08-25 |
| Brandon H. LaVerne | 男 | Interim Chief Executive Officer and Chief Operating Officer | 52 | 58.71万美元 | 未持股 | 2023-08-25 |
董事简历
中英对照 | 中文 | 英文- Richard A. Berman
-
RichardA.Berman自2014年以来一直担任该公司的董事。他是University of South Florida Research and Innovation的战略举措副Vice President、Muma College of Business的社会企业家客座教授，以及创新和高级发现研究所的教授。作为公认的全球领导者，Berman先生曾在医疗保健、教育、政治和管理领域担任职位。他曾与多个外国政府、联合国、美国卫生福利部、FDA合作，并担任纽约州的内阁级官员。他也曾任职McKinsey&Co、NYU Medical Center、Westchester Medical、Korn-Ferry International、Howe-Lewis International和众多创业公司。1995年Berman先生被曼哈顿维尔学院（Manhattanville College）选为其第十任校长。Berman先生被认为是学院的转机，在那里他一直任职到2009年。Berman先生任职于多个组织的董事会，是美国国家科学院（National Academy of Medicine）前身为医学研究所（Institute of Medicine）的当选成员。Berman先生在密歇根大学（University of Michigan）获得工商管理硕士学位和硕士学位，并持有曼哈顿维尔学院（Manhattanville College）和纽约医学院（New York Medical College）的荣誉博士学位。
Richard A. Berman,is the Associate Vice President of Strategic initiatives for the University of South Florida Research and Innovation. He is a visiting professor of social entrepreneurship in the Muma College of Business, and a professor in the institute of innovation and advanced discovery at USF. As a recognized global leader, Mr. Berman has held positions in health care, education, politics and management. He has worked with several foreign governments, the United Nations, the U.S. Department of Health and Welfare, the FDA, and as a cabinet level official for the state of New York. He has also worked with McKinsey & Co, NYU Medical Center, Westchester Medical, Korn-Ferry International, Howe-Lewis International and numerous startup companies. In 1995, Mr. Berman was selected by Manhattanville College to serve as its tenth President. Mr. Berman is credited with the turnaround of the College, where he served until 2009. Mr. Berman serves on the board of several organizations including EmblemHealth and as an elected member of the National Academy of Medicine of the National Academy of Sciences (Formerly known as the Institute of Medicine). Mr. Berman received his BBA, MBA, and MPH from the University of Michigan and holds honorary doctorates from Manhattanville College and New York Medical College. - RichardA.Berman自2014年以来一直担任该公司的董事。他是University of South Florida Research and Innovation的战略举措副Vice President、Muma College of Business的社会企业家客座教授，以及创新和高级发现研究所的教授。作为公认的全球领导者，Berman先生曾在医疗保健、教育、政治和管理领域担任职位。他曾与多个外国政府、联合国、美国卫生福利部、FDA合作，并担任纽约州的内阁级官员。他也曾任职McKinsey&Co、NYU Medical Center、Westchester Medical、Korn-Ferry International、Howe-Lewis International和众多创业公司。1995年Berman先生被曼哈顿维尔学院（Manhattanville College）选为其第十任校长。Berman先生被认为是学院的转机，在那里他一直任职到2009年。Berman先生任职于多个组织的董事会，是美国国家科学院（National Academy of Medicine）前身为医学研究所（Institute of Medicine）的当选成员。Berman先生在密歇根大学（University of Michigan）获得工商管理硕士学位和硕士学位，并持有曼哈顿维尔学院（Manhattanville College）和纽约医学院（New York Medical College）的荣誉博士学位。
- Richard A. Berman,is the Associate Vice President of Strategic initiatives for the University of South Florida Research and Innovation. He is a visiting professor of social entrepreneurship in the Muma College of Business, and a professor in the institute of innovation and advanced discovery at USF. As a recognized global leader, Mr. Berman has held positions in health care, education, politics and management. He has worked with several foreign governments, the United Nations, the U.S. Department of Health and Welfare, the FDA, and as a cabinet level official for the state of New York. He has also worked with McKinsey & Co, NYU Medical Center, Westchester Medical, Korn-Ferry International, Howe-Lewis International and numerous startup companies. In 1995, Mr. Berman was selected by Manhattanville College to serve as its tenth President. Mr. Berman is credited with the turnaround of the College, where he served until 2009. Mr. Berman serves on the board of several organizations including EmblemHealth and as an elected member of the National Academy of Medicine of the National Academy of Sciences (Formerly known as the Institute of Medicine). Mr. Berman received his BBA, MBA, and MPH from the University of Michigan and holds honorary doctorates from Manhattanville College and New York Medical College.
- Michael Sherman
-
Michael Sherman于2018年从Barclays PLC董事总经理的职位上退休，他自2008年以来一直在该公司工作。此前，他曾担任Lehman Brothers，Inc.的董事总经理。他在投资银行工作了30年。他曾为梯瓦制药工业公司、安进公司、Cubist制药公司、Merck&Co.和Cardinal Health等公司从事成功的金融交易。从宾夕法尼亚大学毕业后，Michael Sherman在哈佛大学法学院以优异成绩获得法学博士学位。
Michael Sherman has served as a director of the Company since 2017. He retired from his position as a Managing Director at Barclays Plc in 2018, where he had worked since 2008. Previoly he was a Managing Director at Lehman Brothers, Inc. He has worked in investment banking for 30 years. Mr. Sherman has significant experience in healthcare finance, most recently assisting on a $450 million convertible transaction for Neurocrine Biosciences. He has worked on successful financial transactions for Teva Pharmaceutical Indtries, Amgen Inc., Cubist Pharmaceuticals, Merck & Co., and Cardinal Health, among other companies. After graduating from the University of Pennsylvania, Michael Sherman received his JD, cum laude, from the Harvard Law School. - Michael Sherman于2018年从Barclays PLC董事总经理的职位上退休，他自2008年以来一直在该公司工作。此前，他曾担任Lehman Brothers，Inc.的董事总经理。他在投资银行工作了30年。他曾为梯瓦制药工业公司、安进公司、Cubist制药公司、Merck&Co.和Cardinal Health等公司从事成功的金融交易。从宾夕法尼亚大学毕业后，Michael Sherman在哈佛大学法学院以优异成绩获得法学博士学位。
- Michael Sherman has served as a director of the Company since 2017. He retired from his position as a Managing Director at Barclays Plc in 2018, where he had worked since 2008. Previoly he was a Managing Director at Lehman Brothers, Inc. He has worked in investment banking for 30 years. Mr. Sherman has significant experience in healthcare finance, most recently assisting on a $450 million convertible transaction for Neurocrine Biosciences. He has worked on successful financial transactions for Teva Pharmaceutical Indtries, Amgen Inc., Cubist Pharmaceuticals, Merck & Co., and Cardinal Health, among other companies. After graduating from the University of Pennsylvania, Michael Sherman received his JD, cum laude, from the Harvard Law School.
- James M. Messina
-
James M. Messina是Seattle Hill Ventures和x4 Capital Partners的联合创始人和普通合伙人，这两家公司通过提供业务开发、营销、运营和技术支持来投资和支持初创企业。梅西纳先生以前是Premera Blue Cross（“Premera”）的执行副总裁兼首席运营官。他负责有效地满足Premera客户的需求，监督从客户服务到理赔处理的所有运营职能。梅西纳还领导过销售和营销部门，负责Premera家族所有市场和业务线的增长和收益。在加入Premera之前，Messina先生曾担任CareSite Pharmacies的总裁兼首席执行官。他曾担任消费者驱动型保险公司HealthMarket的首席执行官兼总裁。梅西纳先生还曾在信诺和联合健康担任高级职务。
James M. Messina,is a Co-Founder and General Partner of Seattle Hill Ventures and x4 Capital Partners, which invest in, and support, startup ventures by providing business development, marketing, operating and technology support. Previously, Mr. Messina was the Executive Vice President and Chief Operating Officer for Premera Blue Cross ("Premera"). He was responsible for effectively servicing the needs of Premera's customers with oversight of all operational functions, from customer service to claims processing. Mr. Messina also led Sales and Marketing, responsible for growth and earnings across all markets and business lines throughout the Premera family of companies. Prior to joining Premera, Mr. Messina served as President and Chief Executive Officer of CareSite Pharmacies. He previously served as Chief Executive Officer and President of HealthMarket, a consumer-driven insurance company. Mr. Messina also served in senior level roles at CIGNA and UnitedHealth Group. - James M. Messina是Seattle Hill Ventures和x4 Capital Partners的联合创始人和普通合伙人，这两家公司通过提供业务开发、营销、运营和技术支持来投资和支持初创企业。梅西纳先生以前是Premera Blue Cross（“Premera”）的执行副总裁兼首席运营官。他负责有效地满足Premera客户的需求，监督从客户服务到理赔处理的所有运营职能。梅西纳还领导过销售和营销部门，负责Premera家族所有市场和业务线的增长和收益。在加入Premera之前，Messina先生曾担任CareSite Pharmacies的总裁兼首席执行官。他曾担任消费者驱动型保险公司HealthMarket的首席执行官兼总裁。梅西纳先生还曾在信诺和联合健康担任高级职务。
- James M. Messina,is a Co-Founder and General Partner of Seattle Hill Ventures and x4 Capital Partners, which invest in, and support, startup ventures by providing business development, marketing, operating and technology support. Previously, Mr. Messina was the Executive Vice President and Chief Operating Officer for Premera Blue Cross ("Premera"). He was responsible for effectively servicing the needs of Premera's customers with oversight of all operational functions, from customer service to claims processing. Mr. Messina also led Sales and Marketing, responsible for growth and earnings across all markets and business lines throughout the Premera family of companies. Prior to joining Premera, Mr. Messina served as President and Chief Executive Officer of CareSite Pharmacies. He previously served as Chief Executive Officer and President of HealthMarket, a consumer-driven insurance company. Mr. Messina also served in senior level roles at CIGNA and UnitedHealth Group.
高管简历
中英对照 | 中文 | 英文- Mary Louise Osborne
Mary Louise Osborne，自2023年3月起担任公司总裁，自2022年6月起担任首席商务官。奥斯本女士曾于2022年6月至2023年3月担任公司联席总裁，并于2021年8月至2022年6月担任公司首席客户官。在加入公司之前，奥斯本女士曾于2013年至2020年担任西维斯健康医疗补助地区副总裁。在加入西维斯健康之前，奥斯本女士曾担任考文垂政府业务总裁，并于2002年至2013年领导大西洋中部政府业务。奥斯本女士于1983年在杜肯大学获得文学学士学位。
Mary Louise Osborne,has served as the Company's President since March 2023 and Chief Commercial Officer since June 2022. Ms. Osborne previously served as the Company's Co-President from June 2022 to March 2023 and as the Company's Chief Customer Officer from August 2021 to June 2022. Prior to joining the Company, Ms. Osborne served as the Regional Vice President, Medicaid of CVS Health from 2013 to 2020. Prior to CVS Health, Ms. Osborne served as the President of Government Business for Coventry where she led the Mid Atlantic Government Businesses from 2002 to 2013. Ms. Osborne received her Bachelor of Arts degree from Duquesne University in 1983.- Mary Louise Osborne，自2023年3月起担任公司总裁，自2022年6月起担任首席商务官。奥斯本女士曾于2022年6月至2023年3月担任公司联席总裁，并于2021年8月至2022年6月担任公司首席客户官。在加入公司之前，奥斯本女士曾于2013年至2020年担任西维斯健康医疗补助地区副总裁。在加入西维斯健康之前，奥斯本女士曾担任考文垂政府业务总裁，并于2002年至2013年领导大西洋中部政府业务。奥斯本女士于1983年在杜肯大学获得文学学士学位。
- Mary Louise Osborne,has served as the Company's President since March 2023 and Chief Commercial Officer since June 2022. Ms. Osborne previously served as the Company's Co-President from June 2022 to March 2023 and as the Company's Chief Customer Officer from August 2021 to June 2022. Prior to joining the Company, Ms. Osborne served as the Regional Vice President, Medicaid of CVS Health from 2013 to 2020. Prior to CVS Health, Ms. Osborne served as the President of Government Business for Coventry where she led the Mid Atlantic Government Businesses from 2002 to 2013. Ms. Osborne received her Bachelor of Arts degree from Duquesne University in 1983.
- James J. Park
James J. Park，自2022年6月起担任公司首席财务官，自2021年8月起担任首席会计官，自2019年起担任公司首席会计官。在加入公司之前，Park先生于2012年至2019年担任基于云的软件公司Cornerstone OnDemand，Inc.的财务总监。此外，他在普华永道会计师事务所有10年的公共会计经验。Park先生是一名注册会计师（非在职），拥有加州大学圣巴巴拉分校的经济学学士学位，主修会计学。
James J. Park,has served as the Company's Chief Financial Officer since June 2022, Principal Accounting Officer since August 2021 and Chief Accounting Officer since 2019. Prior to joining the Company, from 2012 to 2019, Mr. Park served as Controller of Cornerstone OnDemand, Inc., a cloud-based software company. In addition, he has 10 years of public accounting experience with PricewaterhouseCoopers. Mr. Park is a Certified Public Accountant (Inactive) and holds a Bachelor of Arts degree in Economics with an Accounting emphasis from the University of California, Santa Barbara.- James J. Park，自2022年6月起担任公司首席财务官，自2021年8月起担任首席会计官，自2019年起担任公司首席会计官。在加入公司之前，Park先生于2012年至2019年担任基于云的软件公司Cornerstone OnDemand，Inc.的财务总监。此外，他在普华永道会计师事务所有10年的公共会计经验。Park先生是一名注册会计师（非在职），拥有加州大学圣巴巴拉分校的经济学学士学位，主修会计学。
- James J. Park,has served as the Company's Chief Financial Officer since June 2022, Principal Accounting Officer since August 2021 and Chief Accounting Officer since 2019. Prior to joining the Company, from 2012 to 2019, Mr. Park served as Controller of Cornerstone OnDemand, Inc., a cloud-based software company. In addition, he has 10 years of public accounting experience with PricewaterhouseCoopers. Mr. Park is a Certified Public Accountant (Inactive) and holds a Bachelor of Arts degree in Economics with an Accounting emphasis from the University of California, Santa Barbara.
- Arik Hill
Arik Hill，自2021年8月起担任公司首席信息官。在加入公司之前，希尔先生曾于2017年至2021年担任The New York Foundling的首席信息官。在加入The New York Funding之前，希尔先生曾于2013年至2017年在HealthEdge Software，Inc.担任客户成功副总裁。2006年至2013年，希尔先生担任FirstCare Health Plans的首席信息官和信息技术服务副总裁。希尔先生拥有俄勒冈州立大学公共卫生学院的卫生保健管理理学学士学位，主修运营管理和商业。
Arik Hill,has served as the Company's Chief Information Officer since August 2021. Prior to joining the Company, Mr. Hill served as the Chief Information Officer of The New York Foundling from 2017 to 2021. Prior to joining The New York Funding, Mr. Hill served as Vice President of Customer Success at HealthEdge Software, Inc. from 2013 to 2017. From 2006 to 2013, Mr. Hill served as Chief Information Officer and Vice President of Information Technology Services at FirstCare Health Plans. Mr. Hill holds a Bachelor of Science degree in Health Care Administration from Oregon State University's School of Public Health with a concentration in Operations Management and Business.- Arik Hill，自2021年8月起担任公司首席信息官。在加入公司之前，希尔先生曾于2017年至2021年担任The New York Foundling的首席信息官。在加入The New York Funding之前，希尔先生曾于2013年至2017年在HealthEdge Software，Inc.担任客户成功副总裁。2006年至2013年，希尔先生担任FirstCare Health Plans的首席信息官和信息技术服务副总裁。希尔先生拥有俄勒冈州立大学公共卫生学院的卫生保健管理理学学士学位，主修运营管理和商业。
- Arik Hill,has served as the Company's Chief Information Officer since August 2021. Prior to joining the Company, Mr. Hill served as the Chief Information Officer of The New York Foundling from 2017 to 2021. Prior to joining The New York Funding, Mr. Hill served as Vice President of Customer Success at HealthEdge Software, Inc. from 2013 to 2017. From 2006 to 2013, Mr. Hill served as Chief Information Officer and Vice President of Information Technology Services at FirstCare Health Plans. Mr. Hill holds a Bachelor of Science degree in Health Care Administration from Oregon State University's School of Public Health with a concentration in Operations Management and Business.
- Judith Feld
Judith Feld，自2022年7月起担任公司首席医疗官。费尔德博士曾于2022年3月至2022年7月担任公司首席临床战略官，并于2020年6月至2022年3月担任公司全国医疗总监。在加入公司之前，费尔德博士于2017年6月至2020年5月担任MVP医疗保健公司的行为健康副总裁。费尔德博士拥有30多年的工作经验，是美国精神病学协会的杰出生命研究员，她因在卡特里娜飓风后在新奥尔良与急救人员一起做的志愿工作而获得了APA的布鲁诺·利马救灾奖。她还获得了大量赠款资金，用于在纽约州实施综合护理模式。费尔德博士拥有宾夕法尼亚大学医学博士学位、SUNY布法罗大学公共卫生硕士学位和南加州大学马歇尔商学院医学管理硕士学位。
Judith Feld,has served as the Company's Chief Medical Officer since July 2022. Dr. Feld previously served as the Company's Chief Clinical Strategy Officer from March 2022 to July 2022 and as the Company's National Medical Director from June 2020 to March 2022. Prior to joining the Company, Dr. Feld served as the Vice President of Behavioral Health at MVP Health Care from June 2017 to May 2020. Dr. Feld is a Distinguished Life Fellow of the American Psychiatric Association, from whom she received the APA's Bruno Lima Award for Disaster Relief for her volunteer work in New Orleans with first responders following Hurricane Katrina. She also has been awarded significant grant funding to implement integrated care models in New York state. Dr. Feld holds an MD from the University of Pennsylvania, a Master of Public Health from SUNY Buffalo, and Master of Medical Management from USC Marshall School of Business.- Judith Feld，自2022年7月起担任公司首席医疗官。费尔德博士曾于2022年3月至2022年7月担任公司首席临床战略官，并于2020年6月至2022年3月担任公司全国医疗总监。在加入公司之前，费尔德博士于2017年6月至2020年5月担任MVP医疗保健公司的行为健康副总裁。费尔德博士拥有30多年的工作经验，是美国精神病学协会的杰出生命研究员，她因在卡特里娜飓风后在新奥尔良与急救人员一起做的志愿工作而获得了APA的布鲁诺·利马救灾奖。她还获得了大量赠款资金，用于在纽约州实施综合护理模式。费尔德博士拥有宾夕法尼亚大学医学博士学位、SUNY布法罗大学公共卫生硕士学位和南加州大学马歇尔商学院医学管理硕士学位。
- Judith Feld,has served as the Company's Chief Medical Officer since July 2022. Dr. Feld previously served as the Company's Chief Clinical Strategy Officer from March 2022 to July 2022 and as the Company's National Medical Director from June 2020 to March 2022. Prior to joining the Company, Dr. Feld served as the Vice President of Behavioral Health at MVP Health Care from June 2017 to May 2020. Dr. Feld is a Distinguished Life Fellow of the American Psychiatric Association, from whom she received the APA's Bruno Lima Award for Disaster Relief for her volunteer work in New Orleans with first responders following Hurricane Katrina. She also has been awarded significant grant funding to implement integrated care models in New York state. Dr. Feld holds an MD from the University of Pennsylvania, a Master of Public Health from SUNY Buffalo, and Master of Medical Management from USC Marshall School of Business.
- Brandon H. LaVerne
Brandon H. LaVerne，2008年7月起担任首席财务官。他此前2007年6月起担任公司临时首席财务官、首席会计师和财务主管，并继续担任首席财务和会计师。2007年6月前，他担任副总裁和财务总监，1998年10月加入公司。此前，他在Computer Sciences Corporation工作，在Deloitte and Touche LLP开始职业生涯。他获有the University of Southern California的会计学学位，也是一名注册会计师。
Brandon H. LaVerne,has served as the Company's Interim Chief Executive Officer since March 2023 and Chief Operating Officer since June 2022. Mr. LaVerne previously served as the Company's Co-President from June 2022 to March 2023 and as the Company's Chief Financial Officer from March 2020 to June 2022. Prior to joining the Company, Mr. LaVerne worked at PCM, Inc. from October 1998 until its sale in August 2019, and most recently served as its Chief Financial Officer, Chief Accounting Officer, Treasurer and Assistant Secretary. Prior to joining PCM, Inc. Mr. LaVerne worked as the Corporate Accounting Supervisor for Computer Sciences Corporation from September 1996 to October 1998. He started his career with Deloitte & Touche LLP in September 1993. Mr. LaVerne received his Bachelor of Science in Accounting from University of Southern California and is a Certified Public Accountant (Inactive).- Brandon H. LaVerne，2008年7月起担任首席财务官。他此前2007年6月起担任公司临时首席财务官、首席会计师和财务主管，并继续担任首席财务和会计师。2007年6月前，他担任副总裁和财务总监，1998年10月加入公司。此前，他在Computer Sciences Corporation工作，在Deloitte and Touche LLP开始职业生涯。他获有the University of Southern California的会计学学位，也是一名注册会计师。
- Brandon H. LaVerne,has served as the Company's Interim Chief Executive Officer since March 2023 and Chief Operating Officer since June 2022. Mr. LaVerne previously served as the Company's Co-President from June 2022 to March 2023 and as the Company's Chief Financial Officer from March 2020 to June 2022. Prior to joining the Company, Mr. LaVerne worked at PCM, Inc. from October 1998 until its sale in August 2019, and most recently served as its Chief Financial Officer, Chief Accounting Officer, Treasurer and Assistant Secretary. Prior to joining PCM, Inc. Mr. LaVerne worked as the Corporate Accounting Supervisor for Computer Sciences Corporation from September 1996 to October 1998. He started his career with Deloitte & Touche LLP in September 1993. Mr. LaVerne received his Bachelor of Science in Accounting from University of Southern California and is a Certified Public Accountant (Inactive).